RECENT FUNDING
  1. Recent Funding
  2. Companies
  3. AnHeart Therapeutics

AnHeart Therapeutics

AnHeart Therapeutics is a developer of innovative pharmaceutical products.

Latest funding

$61M Series B+ ·

Led by Octagon Capital Advisors · Source: startupintros.com

Total raised: $81M across 2 sourced rounds

All 2 rounds ↓
LinkedIn: linkedin.com.
Sectors: Biotechnology.
Stage: Series B+.
Based in: Hangzhou, China.
Founded: 2019.
Total raised: $81M in 2 sourced rounds.
Last round: Dec 14, 2021 · 1,798 days ago.
Headcount: 51–100 employees.
On Recent Funding since: Oct 1, 2026.

Signals

Website registeredNov 14, 2018 (8 years old)
TIMELINE · MONEY RAISED

AnHeart Therapeutics | 635 days from website to first raise on record

Raised $81M in 2 sourced rounds·1 signal before the first raise
$20M$41M$61M$81MDECJAN 2020FEBMARAPRMAYJUNJUL$81M||WEBSITE CREATED · NOV 14, 2018$20M Series A · Aug 10, 2020$20M A · AUG '20$61M Series B+ · Dec 14, 2021$61M B+ · DEC '21

Money raised, round by round (amounts linked to their source). Pins are dated signals; hover the icons for dates.

Funding rounds

DateRoundAmountLeadSource
Series B+$61MOOctagon Capital Advisorsstartupintros.com
Series A$20M—startupintros.com

Timeline

  1. Website created

Founders and team

Investors

Companies like AnHeart Therapeutics

Other companies backed by Octagon Capital Advisors

Octagon Capital Advisors portfolio →

Sources and API

Every amount links to the page it came from. * Estimated from an accelerator's published standard deal, not a company-specific disclosure. How Recent Funding sources and verifies funding data. The same data as JSON: /api/v1/companies/anheart-therapeutics (get a free API key).

Top raises, every week

The week's top funded startups and market insights, in your inbox every Monday.

Unsubscribe anytime · privacy